Autoimmune neutropenia (AIN) has been reported in infants and children, but
not in neonates. AIN is caused by antibodies produced by the patient again
st their own neutrophils; therefore, it differs from the more common alloim
mune neonatal neutropenia and the neonatal neutropenia because of a materna
l autoimmune disease in which antineutrophil antibodies of maternal origin
cross the placenta. We observed 2 cases of congenital AIN in premature neon
ates. These are the youngest reported cases, and indicate that AIN can have
a prenatal onset. Examination of the bone marrow biopsies revealed an incr
ease in B lymphocytes and myeloperoxidase-positive cells with a maturation
arrest at the myelocyte stage. Recombinant human granulocyte colony-stimula
ting factor effectively treated the neutropenia, as it does in infantile AI
N. Ten months after the diagnosis, 1 of the patients still requires recombi
nant human granulocyte colony-stimulating administration.